Enfuvirtide

Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals

Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children

Adding New Drugs for HIV Infected Patients Failing Current Therapy

Study of Valproic Acid to Treat HIV Infected Adults

A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults

A Study of T-20 in HIV-Positive Adults

T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents

Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)

T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs

T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs

Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)

Optimizing Treatment for Treatment-Experienced, HIV-Infected People

Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection

A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy

A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience

Metabolic Effects of Enfuvirtide in Healthy Volunteers

A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) Infection

A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection

Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults

Fuzeon Viral Decay Pilot Study